Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(3):226-235
Currently, there is a lack of evidence for empiric use of antimicrobial agents in most patients with COVID-19 in outpatient and hospital settings as the overall proportion of secondary bacterial infections in COVID-19 is quite low. This literature …